Skip to main content
. 2015 Jul 1;34(15):2008–2024. doi: 10.15252/embj.201490252

Figure 6.

Figure 6

Myc protein expression correlates with effector functions

  • A Lymph node CD8+ T cells were activated with N4 peptide (1 ng/ml) for 2 h, and GFP-Mycneg and GFP-Mycpos populations were FACS-sorted. Expression of IFNγ mRNA measured by qPCR relative to naïve unstimulated CD8+ T cells is shown. Data show mean + SEM of 3 biological replicates.
  • B Flow cytometry data show GFP-Myc and IFNγ expression from spleen OT1 GFP-MycKI CD8+ T cells stimulated with 5 ng/ml Q4 (left panel) or T4 (middle panel) peptides for 24 h. Quadrant percentages are shown. The right panel shows the percentage of GFP-Mycpos and GFP-Mycneg CD8+ T cells expressing IFNγ protein. Data are from 3 biological replicates.
  • C The fluorescence intensity of GFP-Myc and IFNγ expression from flow cytometry data modelled by linear regression in OT1 GFP-MycKI CD8+ T cells treated with 5 ng/ml Q4 for 24 h. Data are representative of 3 biological replicates.
  • D Forward scatter and side scatter plots of CD69+ GFP-Mycneg (upper panels) and CD69+ GFP-Mycpos (lower panel) OT1 GFP-MycKI CD8+ T cells stimulated with 3.3 ng/ml Q4 or N4 peptides for 24 h. Data are representative of 2 biological replicates
  • E, F GFP-MycKI CD8+ T cells were stimulated with CD3 antibody (60 ng/ml) for 24 h. Data are representative of 3 biological replicates. (E) Flow cytometry data show CD69 and GFP-Myc expression. (F) Forward and side scatter plots of CD69 GFP-Mycneg (left panel), CD69+ GFP-Mycneg (middle panel) and CD69+ GFP-Mycpos (right panel) populations.
  • G CD4Cre Mycfl/fl and CD4cre+ Mycfl/fl lymph node cells were activated with CD3 (1 μg/ml) and CD28 (3 μg/ml) antibodies for 24 h. The data show forward and side scatter plots of CD4+ (upper panels) and CD8+ (lower panels) T cells, compared to unstimulated CD4Cre Mycfl/fl cells. Data are representative of at least 3 biological replicates.